Aon Hewitt, the human resource consulting and outsourcing business of Aon Corporation, plans to offer a corporate healthcare exchange to employers nationwide, targeting 1,000 or more full-time employees, beginning as early as 2012.
Aon Hewitt, the human resource consulting and outsourcing business of Aon Corporation, plans to offer a corporate healthcare exchange to employers nationwide, targeting 1,000 or more full-time employees, beginning as early as 2012.
Aon Hewitt has been providing and administering retiree medical exchanges for several years. The Aon Hewitt exchange model is an extension of its retiree medical exchange, which administers retiree benefits to more than 2.4 million participants. In anticipation of changes to the insurance market, the organization is extending its exchange model to offer employers a viable option for active employees.
The company is conducting healthcare conferences for their clients in many cities. At the Chicago and New York events, 243 participants were asked about their plans to provide healthcare coverage to their employees in 2015 and beyond. There was a nearly even split between employers who thought they would ultimately be delivering health benefits via a corporate exchange (43%) vs. continuing to offer healthcare benefits directly with greater financial controls and policies (47%). Meanwhile, 9% said they would continue their attempts to manage the healthcare trend annually, based on current business and economic conditions, and 1% said they do not believe they would be offering healthcare coverage at all in 2015.
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
ICI-Chemo Combo Delivers More Benefit Than Harm, Even for High-Risk NSCLC Patients, Study Finds
May 16th 2025Immune checkpoint inhibitors, such as Opdivo (nivolumab) and Keytruda (pembrolizumab), have been a huge advance in the treatment of non-small cell lung cancer. But it is open question whether they should be combined with traditional chemotherapy.
Read More